These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
3. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)]. Lorenzo Sellares V; Torregrosa V Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742 [TBL] [Abstract][Full Text] [Related]
4. [Renal osteodystrophy (3); its treatment in dialysis patients]. Ghitu S; Oprisiu R; Benamar L; Said S; Tataru Albu A; Arsenescu I; el Esper N; Morinière P; Fournier A Nephrologie; 2000; 21(8):413-24. PubMed ID: 11213385 [TBL] [Abstract][Full Text] [Related]
5. Renal osteodystrophy in dialysis patients: diagnosis and treatment. Fournier A; Oprisiu R; Hottelart C; Yverneau PH; Ghazali A; Atik A; Hedri H; Said S; Sechet A; Rasolombololona M; Abighanem O; Sarraj A; El Esper N; Moriniere P; Boudailliez B; Westeel PF; Achard JM; Pruna A Artif Organs; 1998 Jul; 22(7):530-57. PubMed ID: 9684690 [TBL] [Abstract][Full Text] [Related]
6. Bone health and vascular calcification relationships in chronic kidney disease. Spasovski GB Int Urol Nephrol; 2007; 39(4):1209-16. PubMed ID: 17899431 [TBL] [Abstract][Full Text] [Related]
7. Histologic evolution of bone disease 6 months after successful kidney transplantation. Cruz EA; Lugon JR; Jorgetti V; Draibe SA; Carvalho AB Am J Kidney Dis; 2004 Oct; 44(4):747-56. PubMed ID: 15384027 [TBL] [Abstract][Full Text] [Related]
8. Effects of treatment of renal osteodystrophy on bone histology. Malluche HH; Mawad H; Monier-Faugere MC Clin J Am Soc Nephrol; 2008 Nov; 3 Suppl 3(Suppl 3):S157-63. PubMed ID: 18988701 [TBL] [Abstract][Full Text] [Related]
9. [Ultrasonography methods in the diagnosis of renal osteodystrophy]. Tomić-Brzac H; Pavlović D Acta Med Croatica; 2004; 58(1):43-9. PubMed ID: 15125393 [TBL] [Abstract][Full Text] [Related]
10. Prevention of metabolic bone disease in the pre-end-stage renal disease setting. Coburn JW; Elangovan L J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S71-7. PubMed ID: 11443772 [TBL] [Abstract][Full Text] [Related]
11. Low-turnover bone disease in hypercalcemic hyperparathyroidism after kidney transplantation. Borchhardt K; Sulzbacher I; Benesch T; Födinger M; Sunder-Plassmann G; Haas M Am J Transplant; 2007 Nov; 7(11):2515-21. PubMed ID: 17725680 [TBL] [Abstract][Full Text] [Related]
12. Adynamic bone disease in patients with uremia. Fournier A; Yverneau PH; Hué P; Said S; Hamdini N; Eldin HM; Mohageb S; Oprisiu R; Marie A; Solal ME Curr Opin Nephrol Hypertens; 1994 Jul; 3(4):396-410. PubMed ID: 8076143 [TBL] [Abstract][Full Text] [Related]